The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
Open accessAbstract
Summary Chromosomal translocations affecting Mixed Lineage Leukemia gene (MLL) result in acute leukemias resistant to therapy. The leukemogenic activity of MLL fusion proteins is dependent on their interaction with menin, providing basis for therapeutic intervention. Here we report development of highly potent and orally bioavailable small molecule inhibitors of the menin-MLL interaction, MI-463 and MI-503, show their profound effects in MLL leukemia cells and substantial survival benefit in mouse models of MLL leukemia. Finally, we demonstrate efficacy of these compounds in primary samples derived from MLL leukemia patients. Overall, we demonstrate that pharmacologic inhibition of the menin-MLL interaction represents an effective treatment for MLL leukemias in vivo and provide advanced molecular scaffold for clinical lead identification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513 · cited 2×
“These effects were accompanied by reduced c-kit (CD117) expression, a marker associated with leukemia stem Cancer Cell 27, 589–6 cells (LSCs) (Krivtsov et al., 2006; Somervaille and Cleary, 2006) (Figures S2J and S2K).”
BackgroundSelf-citationInhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C.-W., Hopf, C., Savitski, M. M., et al. (2011) · Nature · doi:10.1038/nature10509 · Cited by 1,503
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Bernt, K. M., Zhu, N., Sinha, A. U., Vempati, S., Faber, J., Krivtsov, A. V., Feng, Z., Punt, N., Daigle, A., Bullinger, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.010 · Cited by 870
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Figueroa, M. E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P. J., Schifano, E., Booth, J., van Putten, W., Skrabanek, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.020 · Cited by 833
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1084 · Cited by 776
Yokoyama, A., Somervaille, T. C. P., Smith, K. S., Rozenblatt-Rosen, O., Meyerson, M., & Cleary, M. L. (2005) · Cell · doi:10.1016/j.cell.2005.09.025 · Cited by 688
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
Somervaille, T. C. P., & Cleary, M. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.020 · Cited by 582
Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes
Yokoyama, A., & Cleary, M. L. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.003 · Cited by 555
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Grembecka, J., He, S., Shi, A., Purohit, T., Muntean, A. G., Sorenson, R. J., Showalter, H. D., Murai, M. J., Belcher, A. M., Hartley, T., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.773 · Cited by 462
Self-citationMLL: a histone methyltransferase disrupted in leukemia
Hess, J. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.005 · Cited by 360
Self-citationThe molecular biology of mixed lineage leukemia
Slany, R. K. (2009) · Haematologica · doi:10.3324/haematol.2008.002436 · Cited by 321
Mll Has a Critical Role in Fetal and Adult Hematopoietic Stem Cell Self-Renewal
McMahon, K. A., Hiew, S. Y.-L., Hadjur, S., Veiga-Fernandes, H., Menzel, U., Price, A. J., Kioussis, D., Williams, O., & Brady, H. J. M. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.002 · Cited by 273
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
Guenther, M. G., Lawton, L. N., Rozovskaia, T., Frampton, G. M., Levine, S. S., Volkert, T. L., Croce, C. M., Nakamura, T., Canaani, E., & Young, R. A. (2008) · Genes & Development · doi:10.1101/gad.1741408 · Cited by 270
MLL rearrangements in haematological malignancies: lessons from clinical and biological studies
DiMartino, J. F., & Cleary, M. L. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01439.x · Cited by 259
Interaction of MLL Amino Terminal Sequences with Menin Is Required for Transformation
Caslini, C., Yang, Z., El-Osta, M., Milne, T. A., Slany, R. K., & Hess, J. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2369 · Cited by 214
Self-citationShi, A., Murai, M. J., He, S., Lund, G., Hartley, T., Purohit, T., Reddy, G., Chruszcz, M., Grembecka, J., & Cierpicki, T. (2012) · Blood · doi:10.1182/blood-2012-05-429274 · Cited by 204
Self-citationMechanisms of leukemogenesis by MLL fusion proteins
Marschalek, R. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08459.x · Cited by 184
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells
Gal, H., Amariglio, N., Trakhtenbrot, L., Jacob‐Hirsch, J., Margalit, O., Avigdor, A., Nagler, A., Tavor, S., Ein‐Dor, L., Lapidot, T., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404401 · Cited by 159
The role of MLL in hematopoiesis and leukemia
Ernst, P., Wang, J., & Korsmeyer, S. J. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00004 · Cited by 157
Self-citationTomizawa, D., Koh, K., Sato, T., Kinukawa, N., Morimoto, A., Isoyama, K., Kosaka, Y., Oda, T., Oda, M., Hayashi, Y., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404903 · Cited by 153
Global Gene Expression Profile of Human Cord Blood–Derived CD133+ Cells
Jaatinen, T., Hemmoranta, H., Hautaniemi, S., Niemi, J., Nicorici, D., Laine, J., Yli-Harja, O., & Partanen, J. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0185 · Cited by 121
He, S., Senter, T. J., Pollock, J., Han, C., Upadhyay, S. K., Purohit, T., Gogliotti, R. D., Lindsley, C. W., Cierpicki, T., Stauffer, S. R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401868d · Cited by 99
Self-citationMolecular Basis of the Mixed Lineage Leukemia-Menin Interaction
Grembecka, J. E., Belcher, A. M., Hartley, T., & Cierpicki, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172783 · Cited by 99
Self-citationWhen epigenetics kills: MLL fusion proteins in leukemia
Slany, R. K. (2005) · Hematological Oncology · doi:10.1002/hon.739 · Cited by 95
富澤, 大. (2010) · Medical Entomology and Zoology · Cited by 93
An MLL-dependent network sustains hematopoiesis
Artinger, E. L., Mishra, B. P., Zaffuto, K. M., Li, B. E., Chung, E. K. Y., Moore, A. W., Chen, Y., Cheng, C., & Ernst, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301278110 · Cited by 85
Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription
Xu, B., Li, S.-H., Zheng, R. Q., Gao, S.-B., Ding, L., Yin, Z., Lin, X., Feng, Z.-J., Zhang, S., Wang, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312022110 · Cited by 82
Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells
Li, B. E., Gan, T., Meyerson, M. M., Rabbitts, T. H., & Ernst, P. (2013) · Blood · doi:10.1182/blood-2013-03-486647 · Cited by 67
Menin regulates the function of hematopoietic stem cells and lymphoid progenitors
Maillard, I. P., Chen, Y.-X., Friedman, A. D., Yang, Y., Tubbs, A., Shestova, O. E., Pear, W. S., & Hua, X. (2008) · Blood · doi:10.1182/blood-2008-01-135012 · Cited by 58
Self-citationThe evolving landscape in the therapy of acute myeloid leukemia
Peloquin, G. L., Chen, Y., & Fathi, A. T. (2013) · Protein & Cell · doi:10.1007/s13238-013-3057-2 · Cited by 26
Cited by
Targeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
Epigenetic modifications of histones in cancer
Zhao, Z., & Shilatifard, A. (2019) · Genome Biology · doi:10.1186/s13059-019-1870-5 · Cited by 552
Epigenetic balance of gene expression by Polycomb and COMPASS families
Piunti, A., & Shilatifard, A. (2016) · Science · doi:10.1126/science.aad9780 · Cited by 524
Krivtsov, A. V., Evans, K., Gadrey, J. Y., Eschle, B. K., Hatton, C., Uckelmann, H. J., Ross, K. N., Perner, F., Olsen, S. N., Pritchard, T., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.11.001 · Cited by 447
Advances in Targeting ‘Undruggable’ transcription Factors With Small Molecules
Henley, M. J., & Koehler, A. N. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00199-0 · Cited by 409
Metadata
- Authors
- Borkin, D., He, S., Miao, H., Kempinska, K., Pollock, J., Chase, J., Purohit, T., Malik, B., Zhao, T., Wang, J., Wen, B., Zong, H., Jones, M., Danet-Desnoyers, G., Guzman, M. L., Talpaz, M., Bixby, D. L., Sun, D., Hess, J. L., Muntean, A. G., Maillard, I., Cierpicki, T., & Grembecka, J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 27
- Issue
- 4
- Pages
- 589-602
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2151718828
- Cited by
- 392
- References
- 34
- FWCI
- 23.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.